𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adenocarcinoma and crohn's disease a report of 2 cases and analysis of the literature

✍ Scribed by S. G. Darke; A. G. Parks; J. L. Grogono; D. J. Pollock

Publisher
John Wiley and Sons
Year
1973
Tongue
English
Weight
655 KB
Volume
60
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Two cases of carcinoma developing in a segment of Crohn's disease are described, one in the large intestine and one in the small intestine. From an analysis of the literature, evidence is advanced with regard to age at the time of developing carcinoma, duration of symptoms attributable to Crohn's disease, anatomical distribution, and observed incidence compared with chance incidence. It is concluded that there is a small but significant risk of carcinoma developing, both in the small and large intestines, in Crohn's disease.

πŸ“œ SIMILAR VOLUMES

Atypical crohn's disease. A report of th
Atypical crohn's disease. A report of three cases
✍ M. J. Bennett-Jones; G. F. Wigglesworth πŸ“‚ Article πŸ“… 1948 πŸ› John Wiley and Sons 🌐 English βš– 612 KB

In I case (0.3 per cent) the duration was stated to be many years. In 18 cases (6.4 per cent) the duration was not stated.

Lewis and Sumner syndrome following infl
Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: A report of 2 cases
✍ Stephane Nancey; FranΓ§oise Bouhour; Gilles Boschetti; Christophe Magnier; Pierre πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 2 views

To the Editor: Neurological and demyelinating events have been reported rarely in association with the use of tumor necrosis factor a (TNF-a) antagonists, since only 29 cases were reported in patients exposed to infliximab (IFX) worldwide. These demyelinating diseases included multiple sclerosis, o